查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
马用医疗保健的全球市场 - 2022年～2029年
市场调查报告书
商品编码
1077246

马用医疗保健的全球市场 - 2022年～2029年

Global Equine Healthcare Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 181 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

本报告提供全球马用医疗保健市场相关调查，提供市场概要，以及各产品类型，各疾病类型，各流通管道，各地区趋势，竞争情形，及加入此市场的主要企业简介等资讯。

目录

第1章 全球马用医疗保健市场调查手法和范围

第2章 全球马用医疗保健市场-市场定义和概要

第3章 全球马用医疗保健市场-摘要整理

  • 各产品类型，市场明细
  • 各疾病类型，市场明细
  • 各流通管道，市场明细
  • 各地区，市场明细

第4章 全球马用医疗保健市场动态

  • 影响市场的要素
    • 促进因素
    • 阻碍因素
    • 市场机会
    • 影响分析

第5章 全球马用医疗保健市场-产业分析

  • 波特的五力分析
  • 供应链分析
  • 法规分析

第6章 全球马用医疗保健市场-COVID-19分析

第7章 全球马用医疗保健市场-各产品类型

  • 简介
    • 市场规模分析，及与前一年同期比较成长分析(%)、各产品类型
    • 市场魅力指数，各产品类型
  • 药物
    • 简介
    • 市场规模分析，100万美元(2020年～2029年)，及与前一年同期比较成长分析(%)(2021年～2029年)
  • 疫苗
  • 补助饲料添加物

第8章 全球马用医疗保健市场-各疾病类型

  • 简介
    • 市场规模分析，及与前一年同期比较成长分析(%)、各疾病类型
    • 市场魅力指数，各疾病类型
  • 马流感
    • 简介
    • 市场规模分析，100万美元(2020年～2029年)，及与前一年同期比较成长分析(%)(2021年～2029年)
  • 鼻肺炎/马传染性贫血
  • 西尼罗河病毒
  • 马狂犬病
  • 波托马克马热
  • 破伤风（锁颚）
  • 其他

第9章 全球马用医疗保健市场-各流通管道

  • 简介
    • 市场规模分析，及与前一年同期比较成长分析(%)、各流通管道
    • 市场魅力指数，各流通管道
  • 兽医医院
    • 简介
    • 市场规模分析，100万美元(2020年～2029年)，及与前一年同期比较成长分析(%)(2021年～2029年)
  • 诊所
  • 零售药局
  • 药妆店
  • 其他

第10章 全球马用医疗保健市场-各地区

  • 简介
    • 市场规模分析，100万美元(2020年～2029年)，及与前一年同期比较成长分析(%)(2021年～2029年)，各地区
    • 市场魅力指数，各地区
  • 北美
  • 欧洲
  • 南美
  • 亚太地区
  • 中东·非洲

第11章 全球马用医疗保健市场-竞争情形

  • 主要的发展与策略
  • 企业占有率分析
  • 产品的基准

第12章 全球马用医疗保健市场-企业简介

  • Purina Animal Nutrition LLC
  • Elanco Animal Health
  • Boehringer Ingelheim
  • Ceva Sante Animale
  • Equine products UK LTD
  • Merck & Co
  • Vetoquinol SA
  • Zoetis

第13章 全球马用医疗保健市场-DataM

简介目录
Product Code: DMVH4998

Market Overview

The global equine healthcare market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX% during the forecast period (2022-2029).

Equine healthcare refers to treating racehorses, bet horses, competitive riders, and leisure horses. Routine veterinarian treatment, such as immunizations, parasite management, and dental care; grooming and hoof care; and protection from natural elements such as rain, wind, and snow are all included in healthcare. Other components of general care and proper feeding and exercising one's horse are required to maintain the horse healthy throughout their life. At least once a year, adult horses should undergo a thorough veterinarian examination.

Market Dynamics

The increasing prevalence of allergies, colic, and mud fever, among other frequent horse healthcare issues, is causing a surge in demand for services. Such discoveries are assisting in the expansion of the equine healthcare sector. Worm infestations, sweet itch, and back difficulties generate cash for market participants.

The Increasing prevalence of equine diseases will drive the market growth

The market's expansion is attributed to factors such as an increase in the prevalence of equine diseases, an increase in the equine population, an increase in animal health expenditure, an increase in demand for the use of horses for various purposes, an increase in advancements of equine healthcare products, an increase in public awareness of the importance and benefits of using horses, and an increase in demand for pet insurance.

Horse breeding, keeping, and overall management are all part of the equestrian industry. It has a significant impact on the economy as a whole. Veterinary physicians, equestrians, and other professionals benefit from the industry. It also includes an equine healthcare product supply and demand scenario. The worldwide equine healthcare market is likely driven by the horse industry's strong economic effect.

In the equine industry, horse breeding is a key operation. As a result, selecting breeding stock and improving breed healthcare management is critical to improving breeding operations. Equine diseases are another big source of concern for breeders. For example, Potomac horse fever is common in South America and the Caribbean.

Although the West Nile Virus infection in horses has been contained, the virus's rapid return may raise the alarm among horse owners. Tetanus and equine influenza cases have also been reported in the global horse community. As a result, the global equine healthcare market is expected to be driven by the increased frequency of equine illnesses.

Declining population of equine is likely to hamper the market growth

The worldwide equine healthcare market is inextricably linked to the world's equine population.According to a study, the horse population in the Americas has decreased by 5.37 percent over the last five years, while the horse population in Europe has decreased by 7.47 percent. As a result, the global horse population is expected to decline throughout the projected period, putting downward pressure on the global equine healthcare market.

COVID-19 Impact Analysis

During the ongoing COVID-19 pandemic, equine practitioners practice tight biosecurity at all farms, performance venues, racetracks, and other locations. It has been shown that recurrent common horse healthcare issues hamper market expansion. To lower reoccurring frequent horse healthcare problems, stakeholders in the equine healthcare market should raise knowledge about regular de-worming regimens and skilled veterinary guidance. Corticosteroids and other therapeutics are commonly utilized as joint injections. Bisphosphonates as tiludronate disodium (Tildren) and clondronate (Osphos) are approved to treat navicular syndrome symptoms. Bisphosphonate use in horses under the age of four requires further investigation.

Segment Analysis

The drugs segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The market is divided into three sections based on product type: drugs, vaccines, and medicated feed additives. In 2020, the drug segment will dominate the global equine healthcare market, which is expected to continue during the forecast period. Key factors such as an increase in demand for pet insurance, an increase in awareness of effective and advanced drugs and vaccines, and an increase in the number of cases of equine diseases may all lead to an increase in hospital admissions. The introduction of effective products that have been tested in clinical trials by companies ensures better therapeutic outcomes.

Geographical Analysis

North America region holds the largest market share of the global equine healthcare market

North America is anticipated to dominate the equine healthcare market, globally. North America's bigger proportion can be linked-to reasons such as the ease with which products and services are available in emerging countries, as well as an increase in animal health expenditure. Overall, the need for equine healthcare in both developing and developed regions of North America is expected to skyrocket in the future years.

In addition, organic and inorganic strategies such as mergers and acquisitions and partnerships within key market players will strengthen their product portfolio in the studied market which will drive the market. Also, several product launches in the market will lead to lucrative growth of the market. For instance, in April 2019, In Europe, Boehringer Ingelheim launched Arti-Cell Forte, a stem cell treatment drug for horses with mild recurring lameness. Furthermore, advancements in various equine healthcare products from established key players, in the United States, are likely to drive the market growth in North America.

Competitive Landscape

The equine healthcare market is highly competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Elanco Animal Health, Boehringer Ingelheim,Ceva Sante Animale, Purina Mills LLC, EQUINE PRODUCTS UK LTD, Merck & Co, Vetoquinol SA, Zoetis, among others.

The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the equine healthcare market globally. For instance, In August 2018, Core EQ Innovator, an equine vaccination against tetanus, rabies, western Equine encephalomyelitis, and two more horse diseases, has been launched by Zoetis.

Purina Animal Nutrition LLC

Overview:

Purina Animal Nutrition LLC, based in Minneapolis, Minnesota, is a subsidiary of Land O'Lakes.

Product Portfolio:

Purina Equine Adult Horse Feed: For horses who are sensitive to soluble carbohydrates, this feed is made without maize or molasses. More control over the carbohydrate and sugar in the horse's diet can be achieved by replacing some or all of the forage.

Why Purchase the Report?

Visualize the composition of the global equine healthcare market segmentation by product type, disease, distribution channel, and region highlighting the key commercial assets and players.

Identify commercial opportunities in the global equine healthcare market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of global equine healthcare market-level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global equine healthcare market report would provide access to an approximately 40+ market data table, 45+ figures, and in the range of 180-200 (approximate) pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Table of Contents

1. Global Equine Healthcare Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Equine Healthcare Market-Market Definition and Overview

3. Global Equine Healthcare Market- Executive Summary

  • 3.1. Market Snippet By Product Type
  • 3.2. Market snippet By Disease Type
  • 3.3. Market Snippet By Distribution Channel
  • 3.4. Market Snippet by Region

4. Global Equine Healthcare Market-Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing prevalence of equine diseases
      • 4.1.1.2. Technological advancements.
    • 4.1.2. Restraints:
      • 4.1.2.1. Declining population of equine.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Equine Healthcare Market- Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. Global Equine Healthcare Market- COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Equine Healthcare Market- By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
    • 7.1.2. Market Attractiveness Index, By Product Type Segment
  • 7.2. Drugs*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Vaccines
  • 7.4. Supplemental Feed Additives

8. Global Equine Healthcare Market- By Disease Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
    • 8.1.2. Market Attractiveness Index, By Disease Type
  • 8.2. Equine Influenza*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Rhinopneumonitis/ Equine Infectious Anemia
  • 8.4. West Nile Virus
  • 8.5. Equine Rabies
  • 8.6. Potomac Horse Fever
  • 8.7. Tetanus(Lockjaw)
  • 8.8. Other

9. Global Equine Healthcare Market- By Distribution Channel

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.1.2. Market Attractiveness Index, By Distribution Channel Segment
  • 9.2. Veterinary Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Clinics
  • 9.4. Retail Pharmacies
  • 9.5. Drug Stores
  • 9.6. Others

10. Global Equine Healthcare Market- By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Global Equine Healthcare Market- Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking

12. Global Equine Healthcare Market- Company Profiles

  • 12.1. Purina Animal Nutrition LLC*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Elanco Animal Health
  • 12.3. Boehringer Ingelheim
  • 12.4. Ceva Sante Animale
  • 12.5. Equine products UK LTD
  • 12.6. Merck & Co
  • 12.7. Vetoquinol SA
  • 12.8. Zoetis

LIST NOT EXHAUSTIVE

13. Global Equine Healthcare Market- DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us